Grup de recerca translacional vascular i renal
- Nombre de publicacions
- 428
Publicacions
-
Purroy F; Sánchez E; Lecube A; Arqué G; Vicente-Pascual M; Mauri-Capdevila G; Torreguitart N; Hernández M; Barbé F; Fernández E; Pamplona R; Farràs C; Mauricio D; Bermúdez-López M
Prevalence and Predictors of Cerebral Microangiopathy Determined by Pulsatility Index in an Asymptomatic Population From the ILERVAS Project.
Frontiers in Neurology 12 785640-785640. .
-
Rojo-López MI; Castelblanco E; Real J; Hernández M; Falguera M; Amigó N; Julve J; Alonso N; Franch-Nadal J; Granado-Casas M; Mauricio D
Advanced Quantitative Lipoprotein Characteristics Do Not Relate to Healthy Dietary Patterns in Adults from a Mediterranean Area.
Nutrients 13 -. .
-
Bermudez-Lopez M; Perpiñan H; Amigo N; Castro E; Alonso N; Mauricio D; Fernandez E; Valdivielso JM
Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients.
CLINICAL KIDNEY JOURNAL 14 2591-2599. .
-
Bermúdez-López M; Martínez-Alonso M; Castro-Boqué E; Betriu À; Cambray S; Farràs C; Barbé F; Pamplona R; Lecube A; Mauricio D; Purroy F; Valdivielso JM; Fernández E; ILERVAS project collaborators
Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study.
REVISTA ESPANOLA DE CARDIOLOGIA 74 1042-1053. .
-
Castelblanco E; Hernández M; Ortega E; Amigó N; Real J; Granado-Casas M; Miñambres I; Lopez C; Lecube A; Bermúdez-López M; Alonso N; Julve J; Mauricio D
Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control.
DIABETES RESEARCH AND CLINICAL PRACTICE 182 109145-109145. .
-
Jatem-Escalante, E; Martin-Conde, ML; Gracia-Lavedan, E; Benitez, ID; Gonzalez, J; Colas, L; Garcia-Carrasco, A; Martinez, C; Segarra-Medrano, A
Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy
CLINICAL KIDNEY JOURNAL 14 2556-2562. .
-
Solache-Berrocal G; Rolle-Sóñora V; Martín-Fernández N; Cambray S; Valdivielso JM; Rodríguez I
CYP24A1 and KL polymorphisms are associated with the extent of vascular calcification but do not improve prediction of cardiovascular events.
NEPHROLOGY DIALYSIS TRANSPLANTATION 36 2076-2083. .
-
Del Carpio, J; Marco, MP; Martin, ML; Craver, L; Jatem, E; Gonzalez, J; Chang, P; Ibarz, M; Pico, S; Falcon, G; Canales, M; Huertas, E; Romero, I; Nieto, N; Segarra, A
External validation of the Madrid Acute Kidney Injury Prediction Score
CLINICAL KIDNEY JOURNAL 14 2377-2382. .
-
Caus M; Eritja À; Bozic M
Role of microRNAs in Obesity-Related Kidney Disease.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. .
-
Valdivielso JM; Balafa O; Ekart R; Ferro CJ; Mallamaci F; Mark PB; Rossignol P; Sarafidis P; Del Vecchio L; Ortiz A
Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.
DRUGS 81 1819-1819. .
-
Castelblanco E; Sarrias MR; Betriu À; Soldevila B; Barranco-Altirriba M; Franch-Nadal J; Valdivielso JM; Bermudez-Lopez M; Groop PH; Fernández E; Alonso N; Mauricio D
Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.
Aging-US 13 22690-22709. .
-
Alonso-Perez E; Forné C; Soro M; Valls M; Manganelli AG; Valdivielso JM
Health Care Costs in Patients with and without Secondary Hyperparathyroidism in Spain.
Advances in Therapy 38 5333-5344. .
